V. Ravery
Impact in
- Urology top 0.5%
- Urological Disorders and Treatments
- Urinary Bladder and Prostate Research
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Kidney Stones and Urolithiasis Treatments
Papers in
-
- Prostate Cancer Diagnosis and Treatment 87
- Prostate Cancer Treatment and Research 73
- Rheumatology 51
- Urologic and reproductive health conditions 40
- Co-authors
- L Boccon-Gibod (44 shared papers)M Toublanc (31 shared papers)V. Delmas (30 shared papers)L. Boccon‐Gibod (8 shared papers)Bob Djavan (21 shared papers)Michael Marberger (20 shared papers)Michaël Peyromaure (8 shared papers)Mesut Remzi (9 shared papers)
In The Last Decade
V. Ravery
146 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 115
- Urology 543
- Pulmonary and Respiratory Medicine 2.5k
- Rheumatology 1.0k
- Cancer Research 398
- Surgery 1.1k
Countries citing papers authored by V. Ravery
This map shows the geographic impact of V. Ravery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Ravery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Ravery more than expected).
Fields of papers citing papers by V. Ravery
This network shows the impact of papers produced by V. Ravery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Ravery. The network helps show where V. Ravery may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Ravery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 322 | |
| 2 | High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. | 1996 | 163 |
| 3 | 1994 | 139 | |
| 4 | 2000 | 132 | |
| 5 | 2012 | 114 | |
| 6 | 1999 | 108 | |
| 7 | 1993 | 99 | |
| 8 | 2002 | 88 | |
| 9 | 2002 | 87 | |
| 10 | Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer. | 1999 | 87 |
| 11 | 2004 | 82 | |
| 12 | 2002 | 81 | |
| 13 | 2001 | 73 | |
| 14 | 2002 | 72 | |
| 15 | 2001 | 72 | |
| 16 | 2013 | 69 | |
| 17 | 1998 | 68 | |
| 18 | 2000 | 67 | |
| 19 | 2005 | 66 | |
| 20 | 1996 | 65 |
About V. Ravery
V. Ravery is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Surgery, Urology and Molecular Biology, having authored 160 papers that have together received 3.7k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (87 papers), Prostate Cancer Treatment and Research (73 papers), Urologic and reproductive health conditions (40 papers), Bladder and Urothelial Cancer Treatments (29 papers), Urological Disorders and Treatments (20 papers), Urinary and Genital Oncology Studies (14 papers), Urinary Bladder and Prostate Research (12 papers) and Ureteral procedures and complications (12 papers). The work is most often cited by research in Urology (543 citations), Pulmonary and Respiratory Medicine (2.5k citations), Rheumatology (1.0k citations), Cancer Research (398 citations) and Surgery (1.1k citations). V. Ravery has collaborated with scholars based in France, Austria and Germany. Frequent co-authors include L Boccon-Gibod, M Toublanc, V. Delmas, L. Boccon‐Gibod, Bob Djavan, Michael Marberger, Michaël Peyromaure, Mesut Remzi, Jean‐François Hermieu and A. Meulemans. Their work appears in journals such as The Journal of Urology, European Urology, Urology, British Journal of Urology and Journal of Endourology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.